PREVALENCE AND CLINICAL RELEVANCE OF CORRECTED QT INTERVAL PROLONGATION DURING METHADONE AND BUPRENORPHINE TREATMENT: A MORTALITY ASSESSMENT STUDY
Saved in:
ANCHERSEN, K., ET AL., PREVALENCE AND CLINICAL RELEVANCE OF CORRECTED QT INTERVAL PROLONGATION DURING METHADONE AND BUPRENORPHINE TREATMENT: A MORTALITY ASSESSMENT STUDY. ADDICTION, Vol. 104, no. 6 (2009), p. 993-999.
Ref.
161034
Location:
SIIS R.696 Archivo
Palabras clave:
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Efectos no deseados, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Efectos no deseados, Metadona, Mortalidad, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento médico
Similar Items: PREVALENCE AND CLINICAL RELEVANCE OF CORRECTED QT INTERVAL PROLONGATION DURING METHADONE AND BUPRENORPHINE TREATMENT: A MORTALITY ASSESSMENT STUDY
- Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy
- QT INTERVAL
- PROLONGED QT INTERVAL IN RETT SYNDROME
- OPIOID MAINTENANCE PATIENTS WITH QTC PROLONGATION: CONGENITAL LONG QT SYNDROME MUTATION MAY BE A CONTRIBUTING RISK FACTOR
- OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE
- PROSPECTIVE COMPARATIVE ASSESSMETN OF BUPRENORPHINE OVERDOSE WITH HEROIN AND METHADONE: CLINICAL CHARACTERISTICS AND RESPONSE TO ANTIDOTAL TREATMENT